Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction

Inclusion Criteria:

- Male and females greater than or equal to 18 years of age

- Diagnosis of RRMS according to revised McDonald Criteria (2010) or (CIS)

- Prescribed BETASERON (note: decision to treat with BETASERON must be made independent
of participation in this study)

- Confirmation of insurance coverage for BETASERON treatment

- Access to a personal computer to complete online patient satisfaction survey at Week 6

Exclusion Criteria:

- Currently enrolled in a clinical trial or other observational study for Multiple
Sclerosis treatment

- Documented substance abuse within the previous 6 months prior to study enrollment

- Any major laboratory value abnormality that the investigator believes would preclude
the patient from participating in the study

- Any medical disorder, condition or history that in the opinion of the investigator
would impair the patient's ability to participate in or complete the study

- Pregnant or nursing